Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

P&G to Help Somaxon Promote Insomnia Drug
Biosmash
Wednesday, August 25, 2010 - 6:56pm
tags:
P&G, drug reps, insomnia, Somaxon, Silenor
Sanofi Moves Closer to Hostile Bid for Genzyme
CNBC
Wednesday, August 25, 2010 - 6:49pm
tags:
Sanofi, Genzyme, M&A
Pfizer, Bristol-Myers to present apixaban data
Yahoo/AP
Wednesday, August 25, 2010 - 6:48pm
tags:
Pfizer, Apixaban, Bristol-Myers Squibb, blood thinners
Meet the Cash Kings of Pharmaceuticals!
Motley Fool
Wednesday, August 25, 2010 - 1:21pm
tags:
Pfizer, Merck, Genzyme
Inspire scuttles eye drug and pencils new deal with Allergan
Fierce Biotech
Wednesday, August 25, 2010 - 12:38pm
tags:
Inspire, Allergan, dry eye disease, Prolacria
Traders Call Bottom in Amylin
Seeking Alpha
Wednesday, August 25, 2010 - 12:33pm
tags:
Amylin
AARP Says Brand-Name Drug Prices Up 8% in 2009
NY Times, NY
Wednesday, August 25, 2010 - 12:27pm
tags:
AARP, drug prices
Small-Cap Biotech Spikes 50% On P&G Deal
Yahoo/IndieResearch
Wednesday, August 25, 2010 - 12:26pm
tags:
P&G, Somaxon, Amarin, Repros Therapeutics, Chelsea Therapeutics, Amicus Therapeutics
Celgene expects patent challenge to Revlimid
Yahoo/AP
Wednesday, August 25, 2010 - 12:21pm
tags:
Celgene, patents, Revlimid, cancer
Sanofi won't go above $70/share for Genzyme: report
Yahoo/Reuters
Wednesday, August 25, 2010 - 12:20pm
tags:
Sanofi, M&A, Genzyme, Allergan, Celgene
Foreign Drugmaker Buyouts Raise Concern in India, Financial Express Says
Bloomberg
Wednesday, August 25, 2010 - 12:19pm
tags:
India, M&A
Patients worry that pharma taints doctors' decisions
Fierce Pharma
Wednesday, August 25, 2010 - 12:18pm
tags:
patients, physicians, physican gifts
[video] They Just Don't Get Pfizer!
TheStreet.com
Wednesday, August 25, 2010 - 12:16pm
tags:
Pfizer
Insulin Users Have 50% Higher Cancer Risk; Causes Are Unclear, Study Says
Bloomberg
Wednesday, August 25, 2010 - 12:15pm
tags:
diabetes, insulin, cancer, Lantus, Sanofi
Elan Defends Alzheimer’s Science
Forbes
Wednesday, August 25, 2010 - 12:12pm
tags:
Elan, Alzheimer's disease, Eli Lilly
Takeda's Actos Has Same Heart Risks as Glaxo's Avandia, Researchers Find
Bloomberg
Wednesday, August 25, 2010 - 7:53am
tags:
diabetes, Takeda, Actos, GSK, Avandia
Stem Cell Competition Heating Up
Seeking Alpha
Wednesday, August 25, 2010 - 7:51am
tags:
stem cells, Aastrom, Athersys, Celgene, Neurostem, Cytori, Geron, Opexa, Osiris, Pluristem, StemCells
Eisai reports upbeat results from PhIII epilepsy study
Fierce Biotech
Tuesday, August 24, 2010 - 6:13pm
tags:
Eisai, clinical trials, epilepsy
Pro Picks In Big Pharma Paying Big Dividends
Yahoo/IndieResearch
Tuesday, August 24, 2010 - 6:07pm
tags:
dividends, Abbott Laboratories, Pfizer, GSK, Eli Lilly, Merck
One Day, the J&J Recalls Will End
Motley Fool
Tuesday, August 24, 2010 - 6:04pm
tags:
recalls, JNJ

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.